Clinical studies reveal a significant correlation between cerebrospinal fluid (CSF) IFN‐β levels and both P‐tau levels and the Aβ42/Aβ40 ratio in AD patients (Wang et al. The gene discussed is MAPT; the disease is Alzheimer disease.